These pathways are potent oncogenic regulators of tumor cell growth, invasion, transformation, and survival. The EGFR is also implicated in angiogenesis, promotes invasiveness through matrix ...

AstraZeneca's EGFR inhibitor Tagrisso has been approved by the FDA for a new lung cancer indication that could make it a ...

To address the unmet need for a cure for RTT, the therapeutic potential of adult Neural Precursor Cells (NPCs) was ...

Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced that we have completed enrollment ...

Ada-Borup West def. EGF Sacred Heart 25-21, 25-18, 25-17 GF Central (kills-blocks-aces) – Jacie Reardon 10-5-0, Gretta Gebhard 9-2-0, Lauren Reardon 5-2-1, Sydney Tollefson 5-1-0, Mya Aure 4-2-0 ...

EAST GRAND FORKS – The East Grand Forks City Council discussed remodeling its Community and Economic Development office during its work session Tuesday. The discussion of the remodel started ...

such as colorectal cancer and other squamous cell carcinomas which typically overexpress EGFR and TGF-beta pathways.” A pivotal Phase 2/3 clinical trial is planned that will test the Bicara ...

Dubai resident Tommy Fleetwood will host three International Pathway Series events annually in the UAE, thanks to an exciting ...

WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca’s TAGRISSO ® (osimertinib) has been approved in the US for the treatment of adult patients with unresectable, Stage III epidermal growth factor ...

In first-line metastatic NSCLC patients with EGFR PACC mutations, the overall response rate by blinded independent central review was 81.8% (n=22; 95% CI, 59.7–94.8%) for those receiving the 240 ...

Aug. 28—BEMIDJI — The Bemidji High School girls tennis team continued its red-hot start to the season at Wednesday's home triangular, sweeping East Grand Forks and Grand Rapids. The ...

The recent FDA approval of Lazcluze plus Rybrevant for EGFR-mutant non-small cell lung cancer is a “big deal” for patients, an oncologist said. Patients with EGFR-mutant non-small cell lung cancer ...